Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Sexually Transmitted Infection Screening

Overview

Guidelines for chlamydia

The U.S. Preventive Services Task Force (USPSTF) recommends chlamydia testing for all sexually active women ages 24 and younger. The USPSTF also recommends testing for women older than 24 with high-risk sexual behaviors. The task force does not state how often to be screened.footnote 1

The Centers for Disease Control and Prevention (CDC) recommends screening every year for sexually active adolescents and women ages 24 and younger. Women older than 24 who have high-risk sexual behaviors also should be screened every year. Gay, bisexual, and other men who have sex with men are also at risk since chlamydia can spread through oral and anal sex. These men should be screened every year as well.footnote 2

The CDC recommends testing during pregnancy for those who are ages 24 and younger or who engage in high-risk sexual behaviors. This helps prevent them from spreading chlamydia to their babies.

The CDC also recommends that you have the test again 3 to 12 months after you finish treatment. People who have been diagnosed and treated for chlamydia may get it again if they have sex with the same untreated partner or partners.footnote 2

Guidelines for syphilis

The U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Preventive Services Task Force (USPSTF) strongly recommend that all pregnant women be screened for syphilis because of the severe consequences of being pregnant while infected or having a child born with congenital syphilis.footnote 3 Screening should be done:footnote 4

  • At the first prenatal visit for all pregnant women.
  • During the third trimester and again at delivery for pregnant women who have an increased risk of acquiring syphilis.footnote 4

The USPSTF also strongly recommends that anyone with high-risk sexual behaviors be screened.

Yearly testing for syphilis is recommended for men who are sexually active with other men. If these men also engage in risky sexual behavior, have HIV, or have a sex partner with syphilis, testing should take place more often.

Guidelines for gonorrhea

The USPSTF recommends testing for all sexually active women ages 24 and younger. The USPSTF also recommends testing for women older than 24 who engage in high-risk sexual behaviors.footnote 1

If you engage in high-risk sexual behaviors, you may want to consider being tested once a year for gonorrhea even though you don't have symptoms. Testing will allow gonorrhea to be quickly diagnosed and treated. This helps to reduce the risk of transmitting gonorrhea and avoid complications of the infection.

The Centers for Disease Control and Prevention (CDC) recommends screening every year for sexually active adolescents and women ages 24 and younger. Women older than 24 who have high-risk sexual behaviors also should be screened every year. Gay, bisexual, and other men who have sex with men are also at risk since gonorrhea can spread through oral and anal sex. These men should be screened every year as well.footnote 2

The CDC recommends testing during pregnancy for those who are ages 24 or younger or who engage in high-risk sexual behaviors. This helps prevent them from transmitting gonorrhea to their babies.footnote 2

The CDC also recommends that you have the test again 3 to 12 months after you finish treatment. People who have been diagnosed and treated for gonorrhea may get it again if they have sex with the same untreated partner or partners.footnote 2

References

Citations

  1. U.S. Preventive Services Task Force (2014). Chlamydia and gonorrhea screening: Final recommendation statement. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/chlamydia-and-gonorrhea-screening. Accessed October 14, 2014.
  2. Centers for Disease Control and Prevention (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR, 64(RR-03): 1–137. http://www.cdc.gov/std/tg2015. Accessed July 2, 2015. [Erratum in MMWR, 64(33): 924. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6433a9.htm?s_cid=mm6433a9_w. Accessed January 25, 2016.]
  3. U.S. Preventive Services Task Force (2018). Screening for syphilis infection in pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. JAMA, 320(9): 911–917. DOI: 10.1001/jama.2018.11785. Accessed January 17, 2019.
  4. Centers for Disease Control and Prevention (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR, 64(RR-03): 1–137. http://www.cdc.gov/std/tg2015. Accessed July 2, 2015. [Erratum in MMWR, 64(33): 924. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6433a9.htm?s_cid=mm6433a9_w. Accessed January 25, 2016.]

Credits

Current as of: April 30, 2024

Author: Ignite Healthwise, LLC Staff
Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Current as of: April 30, 2024

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

Houston Methodist DeBakey Cardiology Associates
6550 Fannin St.
Smith Tower, Suite 1901
Houston, TX 77030

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Houston Cardiovascular Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded HCA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary